华康生物医学(08622)公布2023年业绩 净亏损578.2万元 同比扩大88%
华康生物医学(08622)公布2023年业绩，收益2462.9万元，同比减少2.8%;净亏损578.2万元，同比扩大88%;每股亏损1.39分。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
If you like, reward to support.
Hot
No comment on record. Start new comment.